Literature DB >> 21521427

N-Acetylcysteine reduces early- and late-stage cocaine seeking without affecting cocaine taking in rats.

Jennifer E Murray1, Barry J Everitt, David Belin.   

Abstract

N-acetylcysteine (NAC) has been suggested to have therapeutic potential in the treatment of drug addiction through its effects on brain glutamate homeostasis. Here we show that NAC treatment resulted in dose-dependent reductions in cocaine seeking at both early and late stages of acquisition and maintenance of cocaine-seeking behavior, while confirming it had no effect on cocaine reinforcement. The results indicate that NAC is able to significantly diminish the propensity to seek cocaine early and late in the development of addiction and, taken together with previous work, indicates significant potential in relapse prevention.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521427     DOI: 10.1111/j.1369-1600.2011.00330.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  27 in total

1.  N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order.

Authors:  B Levi Bolin; Joseph L Alcorn; Joshua A Lile; Craig R Rush; Abner O Rayapati; Lon R Hays; William W Stoops
Journal:  Drug Alcohol Depend       Date:  2017-06-29       Impact factor: 4.492

2.  Effects of Methamphetamine Self-Administration and Extinction on Astrocyte Structure and Function in the Nucleus Accumbens Core.

Authors:  B M Siemsen; C M Reichel; K C Leong; C Garcia-Keller; C D Gipson; S Spencer; J A McFaddin; K N Hooker; P W Kalivas; M D Scofield
Journal:  Neuroscience       Date:  2019-03-26       Impact factor: 3.590

3.  High locomotor reactivity to novelty is associated with an increased propensity to choose saccharin over cocaine: new insights into the vulnerability to addiction.

Authors:  Nathalie Vanhille; Aude Belin-Rauscent; Adam C Mar; Eric Ducret; David Belin
Journal:  Neuropsychopharmacology       Date:  2014-08-14       Impact factor: 7.853

Review 4.  Potential role of N-acetylcysteine in the management of substance use disorders.

Authors:  Erin A McClure; Cassandra D Gipson; Robert J Malcolm; Peter W Kalivas; Kevin M Gray
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

5.  A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.

Authors:  Kevin M Gray; Matthew J Carpenter; Nathaniel L Baker; Stacia M DeSantis; Elisabeth Kryway; Karen J Hartwell; Aimee L McRae-Clark; Kathleen T Brady
Journal:  Am J Psychiatry       Date:  2012-08       Impact factor: 18.112

6.  The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine.

Authors:  Yonatan M Kupchik; Khaled Moussawi; Xing-Chun Tang; Xiusong Wang; Benjamin C Kalivas; Rosalia Kolokithas; Katelyn B Ogburn; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2011-12-03       Impact factor: 13.382

7.  Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking.

Authors:  Ilan Sondheimer; Lori A Knackstedt
Journal:  Behav Brain Res       Date:  2011-07-30       Impact factor: 3.332

Review 8.  r

Authors:  Jacqueline S Womersley; Danyelle M Townsend; Peter W Kalivas; Joachim D Uys
Journal:  Eur J Neurosci       Date:  2018-09-24       Impact factor: 3.386

9.  N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking.

Authors:  Ana M Ramirez-Niño; Manoranjan S D'Souza; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

Review 10.  The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis.

Authors:  M D Scofield; J A Heinsbroek; C D Gipson; Y M Kupchik; S Spencer; A C W Smith; D Roberts-Wolfe; P W Kalivas
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.